{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:28:51Z","timestamp":1779917331784,"version":"3.53.1"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The recent emergence of group B streptococcal isolates exhibiting increased penicillin MICs at the Funabashi Municipal Medical Center and other hospitals in Japan prompted a comparative analysis of the penicillin-binding proteins (PBPs) from those strains with the PBPs from penicillin-susceptible strains comprising four neonatal invasive strains isolated from 1976 to 1988 and two recent isolates. The PBP sequences of the penicillin-susceptible strains were highly conserved, irrespective of their isolation date. Of six strains with reduced susceptibility to penicillin (penicillin MICs, 0.25 to 0.5 \u03bcg\/ml), strains R1, R2, R5, and R6 shared a unique set of five amino acid substitutions, including V405A adjacent to the\n            <jats:sub>402<\/jats:sub>\n            SSN\n            <jats:sub>404<\/jats:sub>\n            motif in PBP 2X and one in PBP 2B. The remaining two strains, R3 and R4, shared several substitutions, including Q557E adjacent to the\n            <jats:sub>552<\/jats:sub>\n            KSG\n            <jats:sub>554<\/jats:sub>\n            motif in PBP 2X, in addition to the substitutions in PBP 2B, which are commonly found among penicillin-insusceptible strains. Strains R7 and R8, which had a penicillin MIC of 1 \u03bcg\/ml, shared a unique set of eight amino acid substitutions (two in PBP 2X; two in PBP 2B, including G613R adjacent to the\n            <jats:sub>614<\/jats:sub>\n            KTG\n            <jats:sub>616<\/jats:sub>\n            motif; three in PBP 1A; and one in PBP 2A), and the Q557E substitution in PBP 2X was common to R3 and R4. The binding of Bocillin FL was reduced or not detected in some PBPs, including PBP 2X of penicillin-insusceptible strains, but no significant reduction in the level of\n            <jats:italic>pbp2x<\/jats:italic>\n            transcription was found in such strains. The results of phylogenetic comparative analyses imply the absence of epidemic penicillin-insusceptible strains, and several genetic lineages of penicillin-insusceptible strains have been independently emerging through the accumulation of mutations in their\n            <jats:italic>pbp<\/jats:italic>\n            genes, especially in\n            <jats:italic>pbp2x<\/jats:italic>\n            .\n          <\/jats:p>","DOI":"10.1128\/aac.00596-08","type":"journal-article","created":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T00:45:26Z","timestamp":1222130726000},"page":"4258-4267","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":80,"title":["Genetic Heterogeneity in\n            <i>pbp<\/i>\n            Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility"],"prefix":"10.1128","volume":"52","author":[{"given":"Noriyuki","family":"Nagano","sequence":"first","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo"},{"name":"Medical Microbiology Laboratory, Funabashi Municipal Medical Center, Chiba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo"},{"name":"Miroku Medical Laboratory Co., Ltd., Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideji","family":"Yanagisawa","sequence":"additional","affiliation":[{"name":"Miroku Medical Laboratory Co., Ltd., Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshichika","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Bacterial Pathogenesis and Infection Control, National Institute of Infectious Diseases, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/15.1.77"},{"key":"e_1_3_2_3_2","first-page":"995","year":"1977","unstructured":"Appelbaum, P. C., A. Bhamjee, J. N. Scragg, A. F. Hallett, A. J. Bowen, and R. C. Cooper. 1977. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancetii:995-997.","journal-title":"Lancet"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0732-8893(03)00065-8","volume":"46","year":"2003","unstructured":"Biedenbach, D. J., J. M. Stephen, and R. N. Jones. 2003. Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program\u2014North America, 2001. Diagn. Microbiol. Infect. Dis.46:291-294.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_2_5_2","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6 2003"},{"key":"e_1_3_2_6_2","unstructured":"Performance standards for antimicrobial susceptibility testing 2007"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-08"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3504-3508.2001"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306243282503"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1517"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.62.4.1079-1093.1998"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.202353699"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.4.829"},{"key":"e_1_3_2_14_2","first-page":"264","year":"1967","unstructured":"Hansman, D., and M. M. Bullen. 1967. A resistant pneumococcus. Lancetii:264-265.","journal-title":"Lancet"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.3.1263-1264.2004"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.20.1.128"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3205-3208.2001"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03297.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3605-3609.2003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00185-08"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.3.2.171"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/5.2.150"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10156-002-0230-6","volume":"9","year":"2003","unstructured":"Morikawa, Y., M. Kitazato, C. Katsukawa, and A. Tamaru. 2003. Prevalence of cefotaxime resistance in group B streptococcus isolates from Osaka, Japan. J. Infect. Chemother.9:131-133.","journal-title":"J. Infect. Chemother."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1992.tb01422.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3623-3624.2001"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.12.5530-5536.2003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.8.4643-4649.2002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.28535-0"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313492200"},{"key":"e_1_3_2_30_2","first-page":"604","volume":"77","year":"1991","unstructured":"Regan, J. A., M. A. Klebanoff, R. P. Nugent, et al. 1991. The epidemiology of group B streptococcal colonization in pregnancy. Obstet. Gynecol.77:604-610.","journal-title":"Obstet. Gynecol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13693-8"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.3.497"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07128-1"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1329"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.4.699"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/517408"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4764-4769.1995"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/22.22.4673"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/425368"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/35.1.67","volume":"35","year":"1995","unstructured":"van Asselt, G. J., G. de Kort, and J. A. M. van de Klundert. 1995. Differences in penicillin-binding protein patterns of penicillin tolerant and nontolerant group A streptococci. J. Antimicrob. Chemother.35:67-74.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2495-2497.2005"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00596-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00596-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:10:13Z","timestamp":1645470613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00596-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1128\/AAC.00596-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.00596-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"2008-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-09-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}